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CHARACTERISTICS AND IMPORTANCE OF THE
GENUS PROTOTHECA IN HUMAN AND
VETERINARY MEDICINE
ABSTRACT: Prototheca spp. are strange algae, assigned to the genus Prototheca,
family Chlorelaceae. They are ubiquitous in nature, living predominantly in aqueous locales
containing decomposing plant material. Prototheca spp. were isolated from skin scarificates,
sputum and feces of humans in absence of infection, as well as in a variety of domestic and
some wild animals. Prototheca spp. are unicellular organisms, oval or spheric in shape.
They differ from bacteria and fungi in size, shape and reproductive characteristics. Of the
five known species of the genus, only P. wickerhamii and P. zopfii are considered pathoge-
nic, and they are the only known plant causative agents of human and animal infections.
Over the past 25 years medical references reported more than 100 cases of human protothe-
coses, mostly induced by P. wickerhamii and rarely by P. zopfii. A half of the reports on
human protothecoses relates to localized cutaneous infections and oleocranon bursitis. The
rarest and most severe form of the infection is disseminated or systemic protothecosis, de-
scribed in patients with durable course of primary disease or immune disfunction. In
veterinary medicine, Prototheca zopfii and rarely also P. wickerhamii are reported as causa-
tive agents of cutaneous protothecosis in dogs and cats, systemic protothecosis in dogs and
mastitis in dairy cows. Protothecal infections are diagnosed by histopathology examination
or, more exactly, by isolation of the agent, although the organism cannot be distinguished
from the yeasts by its cultural characteristics. Final diagnosis is made by the carbon-hydrate
assimilation test. Protothecal infections are easily missed in routine practice. Pharmacologi-
cal protocol for therapy of this rare infection has not been developed yet either in human or
in veterinary medicine. Several antifungal agents are aplied for treatment; however, the ef-
fects are variable. Where possible, surgical excision is treatment of choice. Prognosis is
promising in patients with localized infection, and healing is often achieved. Prognosis is
less predictable, mostly bad, in patients with other diseases and in immunocompromized pa-
tients. Sensitivity of Prototheca spp. in vitro does not necessarily correlate with its efficacy
in vivo.
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In 1880, Z o p f and K ü h n first isolated unknown organisms from the
slime flux of a linden tree. The isolates were morphologically and physiolo-
15gically characterized in 1894 by K r ü g e r, who identified them as fungi on
account of their cultural similarity to yeasts (K r ü g e r, 1894). The organisms
were identified as algae in 1913 due to their ability to sporulate similarly as
Chlorella species, and reclassified three years later by West (W e s t, 1916) to
the genus Prototheca, family Chlorelaceae. Prototheca is an achlorophyllous
mutant of the green algae with nonfunctional chloroplast. Achlorophyllous mu-
tants of Chlorellae have been successfully produced in the laboratory; altho-
ugh the pathway of their genesis in natural environment still remains unclear
( H u s s and S o g i n, 1990). Until now, five species have been generally re-
cognized within the genus: P. wickerhamii, P. zopfii, P. moriformis, P. ulmea
and P. stagnora.
DISTRIBUTION
Prototheca spp. is ubiquitous in nature and widely distributed all over the
world. The organism had first been isolated from the slime flux of trees and
over the following decades from a wide variety of sources including sewage,
soil, plants and many fresh and salt water sources, even from water-supply
systems (A n d e r s o n and W a l k e r, 1998; P o r e et al., 1983, W a l s h et
al., 1998). The organism is particularly predominant in aqueous locales contai-
ning decomposing plant material. Prototheca spp. were isolated from skin sca-
rificates, sputum and feces of humans in absence of infection (S o n c k and
K o c h, 1971), as well as in a variety of domestic and some wild animals. Oc-
currence of the organism in the feces of cattle, pig, horses and sheep is associ-
ated with the use of contaminated feed.
Life cycle and morphological traits
Prototheca spp. are monocellular organisms, oval or spherical in shape,
7—16 m in diameter (A n d e r s o n and W a l k e r, 1998; D i P e r s i o,
2001). They differ from bacteria and yeasts in size, shape and reproductive
characteristics. Contrary to yeasts and bacteria they do not have glucosamine
in their cell wall and do not contain muraminic acid, respectively (D i P e r s i o,
2001). The cell wall of Protothecae consists of outer (thinner) and inner
(thicker) envelope, while all Chlorella species (except for Ch. prototecoides)
are characterized by a three-layer cell wall (S u d m a n, 1974). The three spe-
cies commonly isolated from the natural environment are considered non-pat-
hogenic, i. e., P. stagnora, P. ulmea and P. moriformis. These species are able
to produce capsule (similarly to Cryptococcus neoformans); however, this fea-
ture was not observed in any of clinical isolates of P. wickerhamii and P. zopfii
(D i P e r s i o, 2001). The reproduction is asexual, by internal septation and
endospore formation. The sporangia contain 2—16 or more daughter-cells
(sporangiospores), which, following the characteristic cell-wall breakage, furt-
her develop the endosporulating cells (P o r e, 1998).
16Prototheca spp. as causative agent of infection
Of the five known species of the genus, only P. wickerhamii and P. zopfii
are considered pathogenic, yet their pathogenic potential is low. Until now,
they are the only known plant causative agent of human and animal infections
(R o e s l e r et al., 2003).
Human protothecoses
The first case of human protothecosis was described by D a v i e s et al.
in 1964, manifested as localized skin lesions in a farmer in Sierra Leone,
while the first systemic protothecosis was described by C o x et al. in 1974.
Over the past 25 years, medical references reported on more than 100 cases of
human protothecoses, mostly induced by P. wickerhamii and rarely by P. zopfii
(K r c m e r y, 2000; M onopoli e t al., 1995; W i r t h, 1999). Though un-
frequent, protothecal infections are reported worldwide: in Europe, Asia, Afri-
ca and Central America. In our country, the first isolation of Prototheca spp.
from clinical material was reported on April 5, 2005 by the Serbian Micro-
biology Association, Section of Vojvodina (S u v a j d ÿ i ã, 2005). Infections
occur in all age categories, but extremely rarely in the pediatric population.
Described as environment-borne agent, Prototheca spp. enter the body via
the traumatic skin lesion and mucous membranes, on subsequent exposure to
contaminated water. Human-human transmission route is excluded. The incu-
bation period has not been precisely defined yet; however, anamnestic data on
post-traumatic infection suggest a 2-week incubation period.
Some 50% of all reports on human protothecoses relate to localized cuta-
neous infections, slowly-developing single or multiple lesions that do not heal
spontaneously. They are described as diffuse erythema, papulae, vesico-pustu-
les, ulcerations, nodous, eczematous or herpetiform changes located mostly on
extremities. Pain and swelling of soft tissues may occur, as well as various
quantities of serous-sanguineous liquid. Regional lymph nodes are rarely affec-
ted. Failure of prompt diagnosis of cutanous protothecosis may result in the
development of chronic destructive lesions even in immunocompetent indivi-
duals. The second most frequent form of protothecosis is olecranon bursitis,
which develops as a consequence of traumatic implantation of the agent. It is
manifested as induration of the bursa, associated by swelling and moderate
erythema (G a l a n et al., 1997). The rarest and most severe form of the infec-
tion is disseminated or systemic protothecosis, described in patients with dura-
ble course of primary disease or immune dysfunction (diabetes mellitus, mali-
gnancy and chemotherapy, renal transplantation, systemic lupus erythematosus,
corticosteroid therapy and HIV infection) (K unova e t al., 1996).
Animal protothecoses
In veterinary medicine, Prototheca zopfii and rarely also P. wickerhamii
are reported as causative agents of cutaneous protothecosis in dogs and cats,
17systemic protothecosis in dogs and mastitis in dairy cows (G o n z a l e s, 1996,
Monopoli e t al., 1995).
Dogs and cats
Cutaneous protothecosis induced by P. wickerhamii is the only disease
manifestation described in cats (D illberger e tal., 1988). In both cats and
dogs, the cutaneous form results from injury infection and is manifested by the
occurrence of ulcerative lesions, scabs and pyogranulomatous dermatitis in
limbs, trunk and mucous surfaces. Hyperkeratosis may develop too, and fre-
quent complications are due to secondary bacterial infections. Pathohistological
examination of skin bioptates reveals abundant protothecal organisms within
the cytoplasm of phagocytic cells (G i n e l et al., 1997).
In systemic protothecosis in dogs it is most likely that algae enter the
body by ingestion, passing the intestinal mucosa (infection portal) and dissemi-
nating to the entire body via the hematogenic and lymphogenic routes ( H o l -
l i n g s w o r t, 2000). Systemic prorothecosis in dogs is mostly induced by P.
zopfii, rarely by P. wickehamii, and disease symptoms depend on the organs
and organ-systems affected, as well as on the severity of the lesions. Unremar-
kable and unspecific symptoms mostly result in delayed diagnosis, enabling
the agent to spread over the entire body. Even in systemic infections only cu-
taneous manifestations, symptoms of gastro-intestinal disorders and eye infec-
tion were clinically manifested (H o l l i n g s w o r t, 2000; G i n e l et al.,
1997).
Numerous reports have indicated gastrointestinal disorders as most fre-
quent clinical signs of disseminated protothecosis. M i g a k i et al. (1982) de-
scribed hemorrhagic colitis in dogs induced by P. zopfii. The colon is the most
severely affected site, but lesions are visible over the entire intestine. Clinical
manifestation of the disease includes vomiting, tenesmus and intermittent dia-
rrhea (blood and slime in the feces). Colonoscopy reveals diffuse hyperemia,
hemorrhages and ulcerations, as well as multiple granuloma of the mucosa,
which, in the further course of the disease, results in intestinal stricture and
obstipation.
The infection can spread to the central nervous system, cardio-vascular
system and urinary tract, liver, skeletal muscles, lymph nodes, thyroid gland,
pancreas, peritoneum and diaphragm (H o l l i n g s w o r t, 2000). Infection of
the eye is common manifestation of systemic protothecosis in dogs. It results
in severe damages and blindness that are due to development of glaucoma and
retinal ablation. Protothecae are identified by microscopy examination of hu-
mor vitreus (S c h u l t z e et al., 1998). Manifest signs of disease in CNS (cer-
vical pain, depression, ataxia, pareses) are rare. The affected organs exhibit
typical reaction to protothecal infection, i.e., formation of granulomes 0.5—2
mm in diameter with the cell infiltrate composed of cell plasma, macrophages
and neutrophiles.
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Prototheca was first linked to mastitis by L e r c h in 1952. Mastitis in
dairy cows is mostly induced by P. zopfii, sometimes by P. wickerhamii (G o n -
z a l e s, 1996; J a n o s i et al., 1998). P. zopfii mastitis is a disease of highly
productive cows in the machine-milking systems. Although it mostly occurs
sporadically, endemic events are also reported (J a n o s i et al., 2000). Proto-
theca spp. as well as species of Staphylococcus, Streptococcus, Arcanobacte-
rium pyogenes and Mycoplasma may be of great significance for the herd
(Boboš a n d Vidiã ,2003), especially if infection is not timely diagnosed.
Similarly to some bacterial species such as Arcanobacterium pyogenes, Paste-
urella multocida or Corynebacterium ulcerans, Prototheca is rarely identified
as the mastitis agent (S u v a j d ÿ i ã et al., 2001b; S u v a j d ÿ i ã et al., 2003;
S u v a j d ÿ i ã et al., 2001). The wide distribution of these algae in the envi-
ronment and their occurrence and isolation at the farms showing no sign of
protothecal mastitis indicate the crucial role of predisposing factors, such as
poor milking hygiene or prolonged antimicrobial therapy of mastitis of other
etiologies (A n d e r s o n and W a l k e r, 1998; S c h l e n d s t e d t et al.,
1997; T e n h a g e n et al., 1999). Outbreaks of seasonal protothecal mastitis
have been reported during warm and humid periods of the year that promote
the propagation of these organisms in their natural habitat (C o s t a et al.,
1996).
Infection commences at the papillae of mammary glands in all lactation
phases, including dry period (www.Uvex.edu/miklquality/prototheca). In the
first weeks of lactation an increased susceptibility to infection was observed,
which is due to the pronounced energetic misbalance (C o s t a et al., 1997).
The infective dose is not yet defined. In experimental conditions, infusion of
40—480 CFU P. zopfii results in mastitis in 100% cases. Five days after the
experimental infection the alga can be isolated from milk in a yield 20 000—
50 000 CFU/ml (M c D o n a l d et al., 1984a). Anticipated infective doses for
natural infection are high in comparison with other mastitis agents. This
quantity is provided through permanent contact of teeth ends with the primary
infection sources such as soil, plants, water sources and feces. A common in-
fection source is improper sanitation before the mastitis treatment, since the
organism may be introduced via the infusion material, similar as Nocardia
species. Furthermore, cow-to-cow infection during milking is also possible (A n -
d e r s o n and W a l k e r, 1998; D i o n, 1979). Prototheca spp. have been re-
covered from the rubber parts of milking equipment and they showed height
resistance to routine disinfection with chlorine solutions (A n d e r s o n and
W a l k e r, 1998; C o s t a et al., 1997). Despite the observed mixed infections
with Staphylococcus aureus and Streptococcus spp., synergy of P. zopfii and
other bacteria pathogenic for bovine udder was not confirmed (S c h l e n -
s t e d et al., 1997).
Protothecal infections result in chronic manifest subclinical and clinical
mastitis without signs of systemic infection (fever, depression) (T e n h a g e n
et al., 1999). Compared with mastitis forms of other etiologies, the inflam-
matory process is milder during the acute phase. Besides the moderate course
19of the disease and pain, decrease in milk production is observed, associated
with somewhat altered, watery secretion containing clots. The usual antimicro-
bial therapy brings no improvement. Somatic cell count is mostly higher than
1 million/ml; however, individual values may range between 6 and 9 millions/
ml (J a n o s i et al., 1998), sometimes even exceeding 20 millions/ml (M a -
l i n o w s k i et al., 2002). In that respect, even a limited infection may affect
the milk quality within herd. Pursuant to our Regulations on Hygienic Safety
of Milk, the threshold value for somatic cell count in hygienically safe milk is
500,000/ml, while regulations of EU countries do not allow values higher then
300,000/ml (B oboš e tal., 1997). If protothecal infection, especially subcli-
nical one, is present in a herd, the somatic cell count in bulk milk samples
may be the indicator of the suspect agent.
Since there is neither effective therapy nor spontaneous cure, protothecal
infections of the mammary gland become chronic and persist through several
lactating periods. Algae are limited to the mammary gland and regional lymph
nodes exhibiting granulomatous inflammation. Histological lesions are charac-
terized by massive aggregation of macrophages, plasma cells and lymphocytes
( Boboš a n d Vidiã , 2003). Sporangia and sporangiospores are inside the
macrophage and neutrophiles in the alveolar lumen and interstitium, suggesting
that intracellular proliferation is responsible for inability to overcome the in-
fection (J a n o s i et al., 1998). A pathohistological examination of udder tis-
sue in chronic disease course has revealed the progressive interstitial mastitis
with consequent alveolar atrophy (J a n o s i et al., 2001). Such changes of the
mammary gland result in a progressive drop in milk production (C o s t a et
al., 1997; M c D o n a l d et al., 1984b; T e n h a g e n et al., 1999).
Attempts to locate sites containing Protothecae in dairy-cow housings ha-
ve not proved to be successful, as examination of highly-contaminated samples
from the environment does not support such measure (www.Uvex.edu/mikl-
quality/prototheca). Cows should be kept out of humid areas, particularly these
containing manure and decomposing plant material in order to prevent the pa-
pillae from exposure to the infection sources (C o s t a et al., 1996). Proper
draining system will lower the number of microorganisms in the environment.
It is of paramount importance to prevent contact of the teeth ends with feces
and moist manure 25—30 minutes after milking because of the relaxed papilla
sphincter (J a n o s i et al., 1998). If Prototheca is isolated from milk samples,
it is recommended to examine all cows in the herd (H odges e tal., 1985).
Similar to the Mycoplasma bovis and Staphylococcus aureus, Protothecae are
intermittently shed in the milk (G o n z a l e s, 1996). As they may be transfer-
red from cow to cow during milking, it is necessary to separate the infected
animals and milk them last until final exclusion from the herd (A n d e r s o n
and W a l k e r, 1998). Sporadic occurrence of mastitis justifies the culling of
infected animals as a measure for prevention of further spread of the infection.
A failure to promptly diagnose the infection and to apply measures for
prevention of its spreading inevitably results in the culling of infected animals
and decreased milk production and quality, which may cause significant eco-
nomic losses at dairy farms. The program for mastitis control must include al-
so the Prototheca algae (S c h l e n s t e d et al., 1997). Pursuant to legislative
regulations in our country, only the exclusion of Staphylococcus aureus and
20Streptococcus agalactiae is obligatory. As identification of protothecal infecti-
ons is not a part of routine microbiological examination in veterinary medici-
ne, reports on their occurrence are extremely sporadical (M i l a n o v, 2004;
M i l a n o v, 2005). A more complex diagnostic approach including a longer
incubation period and use of restrictive media should become a regular practi-
ce in diagnosing clinical and subclinical mastitis (S u v a j d ÿ i ã et al., 2001a).
Milk and dairy products contaminated with P. zopfii are potential sources
of human infection. An examination of the susceptibility of 40 strains of P.
zopfii isolated from cow milk to different heat-treatment regimens (72—75°C/
15 sec; 72—75°C/20 sec and 62—65°C/30 minutes) revealed resistance in at
least one of the tests in 34 of the examined strains (M e l v ille e tal., 1999).
Diagnosis
Protothecoses are diagnosed by histopathological examination or, more
exactly, by isolation of disease agent.
Histopathological examination
Prototheca spp. are haematoxilinophyllic, hence, staining of tissue section
by haematoxilin-eosin is not the most appropriate method for their identifica-
tion. Visualization of the organism is achieved by Gomori-methenamine silver
or periodic acid-schift (PAS) staining techniques when “morulae" are visible,
mostly bigger than the ones observed in vitro (10—30 m). Empty sporangia
resemble fungi. The sporangia of Prototheca spp. are smaller and contain
fewer spores in comparison with Coccidioides immitis and Rhinosporidium se-
eberi. The organism differs from Blastomyces dermatitidis and Cryptococcus
neoformans by the size, internal structure and lack of budding (D i P e r s i o,
2001). For identification of Protothecae in tissue specimens, the immunofluo-
rescency technique is applied (S u d m a n and K a p l a n, 1973).
Isolation
Prototheca spp. can be recovered (intra vitam) from samples of skin sca-
rificates (cutaneous protothecosis), joint punctuate (bursitis olecranona), feces
(hemorrhagic diarrhea in dogs), urine (urinary infections in dogs) and cow
milk (protothecal mastitis). Material is inoculated on blood agar and Sabou-
raud dextrose agar using standard laboratory techniques. Plates are incubated
for 48—72 h at 25—37°C (M i l a n o v et al., 2003q).
Cultural and biochemical features
Prototheca spp. grows easily on most standard laboratory nutritive media
such as blood agar and Sabouraud-dextrose agar. For isolation from contami-
21nated samples, application of selective media containing inhibitors of normal
microbial flora is recommended. The growth of Prototheca spp. is inhibited by
cycloheximide, yet not by hloramphenicol. A special Prototheca medium con-
tains folate for inhibition of bacterial growth and 5-florocytosine for suppres-
sion of yeast growth. After incubation for 24—72 h at 25—37°C, visible P.
wickerhamii colonies are formed which are smooth, white and yeast-like (D i
P e r s i o, 2001). Colonies of P. zopfii on Sabouraud-dextrose agar are clearly
formed in primary culture after 48—72 hours of incubation. They are mostly
large, irregularly margined, with granular surface and a compact central protru-
sion (J a n o s i et al., 1998; M i l a n o v et al., 2004). Colonies grown on
blood agar are mostly very small and pale gray (M i l a n o v et al., 2004). If
the isolation medium does not contain growth inhibitors, Prototheca colonies
may be overgrown (covered) by bacteria after prolonged incubation (D i P e r -
s i o, 2001). Since it is slow-growing, the organism may easily be missed in
routine practice if incubation is terminated after 24 h (T e n h a g e n et al.,
1999). The colonies are of creamy consistency, readily suspended in saline so-
lution when making microscopy slides. Microscopy is indispensable to distin-
guish Prototheca spp. from yeasts, since differentiation is not possible on the
basis of their cultural features.
Characteristic microscopic appearance of Prototheca spp. is best observed
by examining native preparations using phase-contrast microscopy, when for-
mations described as “morula" or “mulberry" is visible. Prototheca spp. is
easily methyl-blue and Gramm-stained, but heat-fixation may induce morpho-
logical impairment. In Gram-stained preparations, positively stained spores and
Gram-negative empty sporangia are visible (34). Sporangia of P. wickerhamii
are 7—13 m, of P. zopfii 14—16 m in diameter. Final diagnosis is made by
the carbon-hydrate assimilation test (API 20C Bio Merieux; VITEK® Yeast
Biochemical Card; RapID Yeast Plus System-Remel). All Protothecae use glu-
cose as the carbon source. Trechalose assimilation is the key parameter for dif-
ferentiation between the two pathogenic strains. According to phenotype and
genetic criteria, including growth- and biochemical characteristics and sero-
typing, various isolates of P. zopfii are classified into three biotypes. Biotype
II, which ferments glucose and glycerol but not galactose, is mostly isolated in
bovine mastitis and human enteropathies (R o e s l e r et al., 2003).
Therapy and prognosis
Pharmacological protocol for therapy of this rare infection has not been
developed yet either in human or in veterinary medicine. Several antifungal
agents are applied for treatment; however, the observed effects are variable. In
human medicine, Amphotericin B, a product of Streptomyces nodosus (S u -
v a j d ÿ i ã, 2004), is used for therapy of disseminated protothecosis. This is a
funghistatic or fungicide that inhibits ergosterole synthesis in the cell membra-
ne of Prototheca spp. The drug has proven to be nephrotoxic, and confirmed
oversusceptibility is contraindication to its use. Administration of immidazoles,
such as itracosanole, ketoconasole, fluconasole and clorimazole, may show so-
22me improvement; however, their efficacy is not yet confirmed due to variable
clinical response. Where possible, surgical excision is the treatment of choice.
Prognosis is promising in patients with localized infection, and healing is often
achieved. Prognosis is less predictable, mostly bad, in patients with other dise-
ases and in immunocompromised patients.
Therapy of systemic protothecosis in dogs may include amphotericin B,
tetracyclin, ketoconasole, itraconasole, fluconasole and chorimazole; however,
outcomes of such therapies are not yet established. Cutaneous protothecosis
caused by P. wickerhamii requires both medicamentous treatment and surgical
excision.
In vitro isolates of P. zopfii from milk exhibited sensitivity to amphothe-
ricin B, nystatin, polymyxin B, gentamicin and neomycin (M c D o n a l d et
al., 1984b; M a l i n o w s k i et al., 2002). Effective therapy of protothecal
mastitis has not yet been developed and the only measure to control the spread
of infection in the herd is exclusion of infected animals.
Sensitivity of Prototheca spp. in vitro does not necessarily correlate with
its efficacy in vivo.
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Rezime
Prototheca spp. su relativno nepoznate alge, svrstane u genus Prototheca,
familije Chlorelaceae. Ubikvitarne su prirodi i wihova rasprostrawenost je
uglavnom vezana za vlaÿna podruåja koja sadrÿe biqnu materiju u raspadawu,
ali su izolovane i iz koÿnih skarifikata, sputuma i fecesa qudi, kao i iz
26niza domaãih i nekih vrsta divqih ÿivotiwa. Prototheca spp. su jednoãelijski
organizmi ovalnog ili sferiånog oblika koji se od bakterija i gqiva razlikuju
po veliåini, obliku i naåinu reprodukcije. Od pet poznatih vrsta ovog roda,
samo se P. wickerhamii i P. zopfii smatraju patogenima i, dosada, one su jedini
poznati biqni uzroåni agens infekcija qudi i ÿivotiwa. U posledwih 25 go-
dina u medicinskoj literaturi opisano je više od 100 sluåajeva humanih proto-
tekoza, uglavnom izazvanih algama P. wickerhamii, a reðe P. zopfii. Oko polovina
svih izveštaja humanih prototekoza odnosi se na lokalizovane koÿne infekci-
je i bursitis olekranona. Najreða i najteÿa forma infekcije je diseminirana
ili sistemska prototekoza, opisana kod pacijenata sa drugim osnovnim oboqe-
wem ili imunološkom disfunkcijom. U veterinarskoj medicini Prototheca zop-
fii a reðe i P. wickerhamii navode se kao uzroånici kutane prototekoze pasa i
maåaka, sistemske prototekoze pasa i mastitisa mleånih krava. Prototekalne
infekcije se mogu dijagnostikovati patohistološkim pregledom ili egzaktnije,
izolacijom uzroånika, mada se od kvasnica ne mogu razlikovati samo na osnovu
kulturelnih osobina. Definitivna dijagnoza postavqa se testom ugqeno-hi-
dratne asimilacije. Problem kod ovih infekcija je što se na wih retko posum-
wa i nisu predmet rutinske laboratorijske prakse. Ni u humanoj ni u veteri-
narskoj medicini nema definisanog farmakološkog protokola u terapiji. Ne-
koliko antifungalnih agenasa koristi se u terapiji sa razliåitim efektom.
Tamo gde je moguãe, s obzirom na lokalizaciju, tretman izbora je hirurška eks-
cizija. Kod pacijenata sa lokalizovanom infekcijom prognoza je dobra i obiå-
no se postiÿe izleåewe. Prognoza kod pacijenata sa drugim oboqewima i imu-
nosupresijom mawe je predvidiva i moÿe biti loša. Osetqivost Prototheca spp.
na antifungalne agense in vitro ne mora biti u korelaciji sa in vivo efikasno-
šãu.
27